| Serial Number | 88755251 |
| Word Mark | A |
| Filing Date | Friday, January 10, 2020 |
| Status | 700 - REGISTERED |
| Status Date | Tuesday, November 24, 2020 |
| Registration Number | 6203857 |
| Registration Date | Tuesday, November 24, 2020 |
| Mark Drawing | 3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s) |
| Published for Opposition Date | Tuesday, September 8, 2020 |
| Indication of Colors claimed | Color is not claimed as a feature of the mark. |
| Description of Mark | The mark consists of a stylized letter "A" within an incomplete ellipse with a chevron used for the cross bar in the letter. |
| Goods and Services | Biological research; Biotechnology research; Consultancy pertaining to pharmacology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; Drug discovery services; Pharmaceutical drug development services; Pharmaceutical product evaluation; Pharmaceutical products development; Pharmaceutical research and development; Pharmaceutical research services; Chemical, biochemical, biological and bacteriological research and analysis; Development of pharmaceutical preparations and medicines; Laboratory research services relating to pharmaceuticals; Product development consultation; Providing information on the subject of scientific research in the field of biochemistry and biotechnology; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research and development in the pharmaceutical and biotechnology fields; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development services in the field of antibodies; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Testing of pharmaceuticals |
| Pseudo Mark | ADEPT |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, January 16, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, December 10, 2019 |
| First Use In Commerce Date | Tuesday, December 10, 2019 |
| Party Name | Adept Therapeutics Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | Bedford, MA 01730 |
| Party Name | Adept Therapeutics Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Bedford, MA 01730 |
| Party Name | Adept Therapeutics Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Bedford, MA 01730 |
| Event Date | Event Description |
| Tuesday, November 24, 2020 | REGISTERED-PRINCIPAL REGISTER |
| Tuesday, September 8, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, September 8, 2020 | PUBLISHED FOR OPPOSITION |
| Wednesday, August 19, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, August 4, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, July 14, 2020 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, July 13, 2020 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, July 13, 2020 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Monday, March 30, 2020 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, March 30, 2020 | NON-FINAL ACTION E-MAILED |
| Monday, March 30, 2020 | NON-FINAL ACTION WRITTEN |
| Sunday, March 29, 2020 | ASSIGNED TO EXAMINER |
| Friday, January 17, 2020 | NOTICE OF DESIGN SEARCH CODE E-MAILED |
| Thursday, January 16, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Tuesday, January 14, 2020 | NEW APPLICATION ENTERED IN TRAM |